Krishna Institute of Medical Sciences Limited (KIMS Hospitals) announced its unaudited financial results for the first quarter ended June 30, 2026 (Q1 FY27). The company reported a 36.1% year-on-year growth in total revenue, reaching INR 1,196 crore. EBITDA also saw a significant increase of 20.1% to INR 240 crore. The report also highlights operational updates and clinical achievements across its network of hospitals.
KIMS Hospitals Announces Strong Q1 FY27 Financial Performance
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has reported a robust performance for the first quarter of the fiscal year 2027 (Q1 FY27), ending June 30, 2026. The Board of Directors approved financial results that indicate substantial year-on-year growth.
Q1 FY27 Financial Highlights
Key financial updates for Q1 FY27 include:
- Total Revenue: Increased by 36.1% year-on-year (YoY) and 10.3% quarter-on-quarter (QoQ) to INR 1,196 crore.
- EBITDA: Grew by 20.1% YoY and 10.9% QoQ to INR 240 crore. The EBITDA margin stood at 20.1%.
- PAT: Reported at INR 37 crore.
- Consolidated EPS: At INR 1.04, a degrowth of 47.2% on a YoY basis.
- Cash and Cash Equivalents: Stood at INR 505 crore as of June 30, 2026.
Operational and Clinical Achievements
The company also shared operational highlights, including a 35.3% YoY growth in Consolidated Revenue from Operations to INR 1,180 crore. Consolidated EBITDA (Pre-INDAS) saw a 14.6% YoY growth to INR 222 crore.
The press release details numerous clinical achievements across KIMS Secunderabad, KIMS Kondapur, KIMS ICON Vizag, KIMS KINGSWAY NAGPUR, KIMS SUNSHINE, KIMS Saveera – Anantapur, and KIMS Seethammadhara. These include complex surgeries, successful organ transplants, and innovative treatment procedures, underscoring the hospital group’s advanced medical capabilities and commitment to patient care.
KIMS Hospitals also announced the addition of a new hospital in Palakkad, Kerala, in Q1 FY27, contributing to its expanding network and operational footprint.
Source: BSE
